Large-scale testing (Phase 3)Study completedNCT00150800
What this trial is testing
This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment
Who this might be right for
Epilepsy
UCB PHARMA Inc. (US) 668